Illumina (ILMN) Competitors $144.46 -0.37 (-0.26%) As of 01:41 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ILMN vs. QGEN, TMO, WAT, A, and MTDShould you buy Illumina stock or one of its competitors? MarketBeat compares Illumina with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Illumina include Qiagen (QGEN), Thermo Fisher Scientific (TMO), Waters (WAT), Agilent Technologies (A), and Mettler-Toledo International (MTD). These companies are all part of the "medical" sector. ILMN vs. QGENILMN vs. TMOILMN vs. WATILMN vs. AILMN vs. MTDHow does Illumina compare to Qiagen?Qiagen (NYSE:QGEN) and Illumina (NASDAQ:ILMN) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, risk, profitability, media sentiment and valuation. Is QGEN or ILMN more profitable? Illumina has a net margin of 19.42% compared to Qiagen's net margin of 19.16%. Illumina's return on equity of 31.01% beat Qiagen's return on equity.Company Net Margins Return on Equity Return on Assets Qiagen19.16% 14.40% 8.40% Illumina 19.42%31.01%12.22% Does the media refer more to QGEN or ILMN? In the previous week, Illumina had 12 more articles in the media than Qiagen. MarketBeat recorded 20 mentions for Illumina and 8 mentions for Qiagen. Illumina's average media sentiment score of 0.96 beat Qiagen's score of 0.10 indicating that Illumina is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Qiagen 0 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Illumina 9 Very Positive mention(s) 5 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Do analysts rate QGEN or ILMN? Qiagen currently has a consensus target price of $44.98, indicating a potential upside of 27.68%. Illumina has a consensus target price of $137.75, indicating a potential downside of 4.64%. Given Qiagen's stronger consensus rating and higher probable upside, analysts clearly believe Qiagen is more favorable than Illumina.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Qiagen 0 Sell rating(s) 7 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.50Illumina 2 Sell rating(s) 9 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.28 Which has higher earnings and valuation, QGEN or ILMN? Illumina has higher revenue and earnings than Qiagen. Qiagen is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQiagen$2.09B3.47$424.88M$1.9118.44Illumina$4.34B5.03$850M$5.5026.27 Which has more risk & volatility, QGEN or ILMN? Qiagen has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market. Comparatively, Illumina has a beta of 1.42, indicating that its share price is 42% more volatile than the broader market. Do insiders & institutionals believe in QGEN or ILMN? 70.0% of Qiagen shares are owned by institutional investors. Comparatively, 89.4% of Illumina shares are owned by institutional investors. 9.0% of Qiagen shares are owned by insiders. Comparatively, 2.9% of Illumina shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryIllumina beats Qiagen on 13 of the 17 factors compared between the two stocks.How does Illumina compare to Thermo Fisher Scientific?Illumina (NASDAQ:ILMN) and Thermo Fisher Scientific (NYSE:TMO) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends. Which has more risk and volatility, ILMN or TMO? Illumina has a beta of 1.42, suggesting that its stock price is 42% more volatile than the broader market. Comparatively, Thermo Fisher Scientific has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market. Which has higher earnings and valuation, ILMN or TMO? Thermo Fisher Scientific has higher revenue and earnings than Illumina. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIllumina$4.34B5.03$850M$5.5026.27Thermo Fisher Scientific$45.20B3.67$6.70B$18.1924.57 Is ILMN or TMO more profitable? Illumina has a net margin of 19.42% compared to Thermo Fisher Scientific's net margin of 15.15%. Illumina's return on equity of 31.01% beat Thermo Fisher Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Illumina19.42% 31.01% 12.22% Thermo Fisher Scientific 15.15%16.86%8.15% Do analysts rate ILMN or TMO? Illumina currently has a consensus price target of $137.75, suggesting a potential downside of 4.64%. Thermo Fisher Scientific has a consensus price target of $616.10, suggesting a potential upside of 37.85%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Thermo Fisher Scientific is more favorable than Illumina.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Illumina 2 Sell rating(s) 9 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.28Thermo Fisher Scientific 0 Sell rating(s) 3 Hold rating(s) 18 Buy rating(s) 2 Strong Buy rating(s) 2.96 Does the media favor ILMN or TMO? In the previous week, Thermo Fisher Scientific had 38 more articles in the media than Illumina. MarketBeat recorded 58 mentions for Thermo Fisher Scientific and 20 mentions for Illumina. Thermo Fisher Scientific's average media sentiment score of 1.24 beat Illumina's score of 0.96 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Illumina 9 Very Positive mention(s) 5 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Thermo Fisher Scientific 41 Very Positive mention(s) 4 Positive mention(s) 10 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of ILMN or TMO? 89.4% of Illumina shares are owned by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are owned by institutional investors. 2.9% of Illumina shares are owned by company insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryThermo Fisher Scientific beats Illumina on 9 of the 17 factors compared between the two stocks.How does Illumina compare to Waters?Illumina (NASDAQ:ILMN) and Waters (NYSE:WAT) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations, risk and media sentiment. Do institutionals & insiders hold more shares of ILMN or WAT? 89.4% of Illumina shares are owned by institutional investors. Comparatively, 94.0% of Waters shares are owned by institutional investors. 2.9% of Illumina shares are owned by insiders. Comparatively, 0.3% of Waters shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is ILMN or WAT more profitable? Illumina has a net margin of 19.42% compared to Waters' net margin of 11.91%. Illumina's return on equity of 31.01% beat Waters' return on equity.Company Net Margins Return on Equity Return on Assets Illumina19.42% 31.01% 12.22% Waters 11.91%15.60%8.90% Does the media favor ILMN or WAT? In the previous week, Illumina had 16 more articles in the media than Waters. MarketBeat recorded 20 mentions for Illumina and 4 mentions for Waters. Waters' average media sentiment score of 1.01 beat Illumina's score of 0.96 indicating that Waters is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Illumina 9 Very Positive mention(s) 5 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Waters 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, ILMN or WAT? Illumina has a beta of 1.42, suggesting that its share price is 42% more volatile than the broader market. Comparatively, Waters has a beta of 1.14, suggesting that its share price is 14% more volatile than the broader market. Which has preferable valuation and earnings, ILMN or WAT? Illumina has higher revenue and earnings than Waters. Illumina is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIllumina$4.34B5.03$850M$5.5026.27Waters$3.77B8.87$642.63M$7.8743.25 Do analysts rate ILMN or WAT? Illumina presently has a consensus target price of $137.75, suggesting a potential downside of 4.64%. Waters has a consensus target price of $396.00, suggesting a potential upside of 16.33%. Given Waters' stronger consensus rating and higher possible upside, analysts plainly believe Waters is more favorable than Illumina.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Illumina 2 Sell rating(s) 9 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.28Waters 0 Sell rating(s) 8 Hold rating(s) 9 Buy rating(s) 3 Strong Buy rating(s) 2.75 SummaryWaters beats Illumina on 9 of the 17 factors compared between the two stocks.How does Illumina compare to Agilent Technologies?Agilent Technologies (NYSE:A) and Illumina (NASDAQ:ILMN) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, risk, institutional ownership, profitability and valuation. Which has more risk & volatility, A or ILMN? Agilent Technologies has a beta of 1.22, indicating that its stock price is 22% more volatile than the broader market. Comparatively, Illumina has a beta of 1.42, indicating that its stock price is 42% more volatile than the broader market. Do insiders & institutionals believe in A or ILMN? 89.4% of Illumina shares are owned by institutional investors. 2.9% of Illumina shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has higher valuation & earnings, A or ILMN? Agilent Technologies has higher revenue and earnings than Illumina. Agilent Technologies is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgilent Technologies$6.95B4.67$1.30B$4.5325.36Illumina$4.34B5.03$850M$5.5026.27 Do analysts rate A or ILMN? Agilent Technologies presently has a consensus price target of $163.71, indicating a potential upside of 42.51%. Illumina has a consensus price target of $137.75, indicating a potential downside of 4.64%. Given Agilent Technologies' stronger consensus rating and higher probable upside, equities research analysts plainly believe Agilent Technologies is more favorable than Illumina.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agilent Technologies 0 Sell rating(s) 2 Hold rating(s) 11 Buy rating(s) 2 Strong Buy rating(s) 3.00Illumina 2 Sell rating(s) 9 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.28 Is A or ILMN more profitable? Illumina has a net margin of 19.42% compared to Agilent Technologies' net margin of 18.26%. Illumina's return on equity of 31.01% beat Agilent Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Agilent Technologies18.26% 24.49% 12.83% Illumina 19.42%31.01%12.22% Does the media prefer A or ILMN? In the previous week, Illumina had 6 more articles in the media than Agilent Technologies. MarketBeat recorded 20 mentions for Illumina and 14 mentions for Agilent Technologies. Illumina's average media sentiment score of 0.96 beat Agilent Technologies' score of 0.29 indicating that Illumina is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 1 Very Positive mention(s) 2 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Illumina 9 Very Positive mention(s) 5 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive SummaryIllumina beats Agilent Technologies on 10 of the 17 factors compared between the two stocks.How does Illumina compare to Mettler-Toledo International?Mettler-Toledo International (NYSE:MTD) and Illumina (NASDAQ:ILMN) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, media sentiment, institutional ownership, analyst recommendations and profitability. Which has more risk and volatility, MTD or ILMN? Mettler-Toledo International has a beta of 1.31, meaning that its stock price is 31% more volatile than the broader market. Comparatively, Illumina has a beta of 1.42, meaning that its stock price is 42% more volatile than the broader market. Do institutionals & insiders hold more shares of MTD or ILMN? 95.1% of Mettler-Toledo International shares are held by institutional investors. Comparatively, 89.4% of Illumina shares are held by institutional investors. 0.7% of Mettler-Toledo International shares are held by insiders. Comparatively, 2.9% of Illumina shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts recommend MTD or ILMN? Mettler-Toledo International presently has a consensus price target of $1,408.55, suggesting a potential upside of 27.84%. Illumina has a consensus price target of $137.75, suggesting a potential downside of 4.64%. Given Mettler-Toledo International's stronger consensus rating and higher possible upside, research analysts plainly believe Mettler-Toledo International is more favorable than Illumina.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mettler-Toledo International 0 Sell rating(s) 6 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.50Illumina 2 Sell rating(s) 9 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.28 Does the media refer more to MTD or ILMN? In the previous week, Illumina had 15 more articles in the media than Mettler-Toledo International. MarketBeat recorded 20 mentions for Illumina and 5 mentions for Mettler-Toledo International. Illumina's average media sentiment score of 0.96 beat Mettler-Toledo International's score of -0.05 indicating that Illumina is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mettler-Toledo International 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Illumina 9 Very Positive mention(s) 5 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Is MTD or ILMN more profitable? Mettler-Toledo International has a net margin of 21.40% compared to Illumina's net margin of 19.42%. Illumina's return on equity of 31.01% beat Mettler-Toledo International's return on equity.Company Net Margins Return on Equity Return on Assets Mettler-Toledo International21.40% -622.80% 24.97% Illumina 19.42%31.01%12.22% Which has stronger valuation & earnings, MTD or ILMN? Mettler-Toledo International has higher earnings, but lower revenue than Illumina. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMettler-Toledo International$4.03B5.53$869.19M$42.6425.84Illumina$4.34B5.03$850M$5.5026.27 SummaryMettler-Toledo International and Illumina tied by winning 8 of the 16 factors compared between the two stocks. Get Illumina News Delivered to You Automatically Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ILMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ILMN vs. The Competition ExportMetricIlluminaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.88B$3.38B$6.38B$12.34BDividend YieldN/A2.30%2.79%5.33%P/E Ratio26.2919.0420.9125.65Price / Sales5.03298.20543.8085.61Price / Cash21.14129.8244.1356.16Price / Book8.176.9810.097.06Net Income$850M$24.45M$3.55B$335.04M7 Day Performance1.35%3.54%4.71%2.60%1 Month Performance10.70%-0.26%1.43%1.42%1 Year Performance79.36%62.90%36.72%35.67% Illumina Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ILMNIllumina3.2489 of 5 stars$144.46-0.3%$137.75-4.6%+82.5%$21.88B$4.34B26.298,650QGENQiagen4.5697 of 5 stars$33.67+3.2%$46.38+37.8%-21.6%$6.72B$2.09B17.585,654TMOThermo Fisher Scientific4.8493 of 5 stars$459.01+1.4%$619.65+35.0%+13.0%$168.20B$45.20B25.23125,000Positive NewsDividend AnnouncementWATWaters4.214 of 5 stars$351.76+1.1%$395.12+12.3%-1.7%$34.17B$3.17B44.707,900AAgilent Technologies4.867 of 5 stars$112.93+1.3%$163.71+45.0%+5.5%$31.50B$6.95B24.9318,100Upcoming EarningsDividend Announcement Related Companies and Tools Related Companies Qiagen Alternatives Thermo Fisher Scientific Alternatives Waters Alternatives Agilent Technologies Alternatives Mettler-Toledo International Alternatives Charles River Laboratories International Alternatives Bio-Techne Alternatives Bruker Alternatives Bio-Rad Laboratories Alternatives Pacific Biosciences of California Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ILMN) was last updated on 5/22/2026 by MarketBeat.com Staff. From Our PartnersThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredThis stock has 30 days of quiet leftA small power equipment company with $1.5 billion in orders is flying under the radar - but not for long. When...Behind the Markets | SponsoredMaybe the Greatest Strategy of the DecadeNate Bear, Lead Technical Tactician at Monument Traders Alliance, is going public with his highest-conviction ...Monument Traders Alliance | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredElon’s Biggest Launch Ever: 15x Bigger Than SpaceXThe Man Who Called Nvidia Before It Soared 1,000% Issues New Elon Musk BUY Alert Luke Lango was ranked Amer...InvestorPlace | Sponsored"Computers are about to become obsolete" - George Gilder. Here’s why.George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and ...Eagle Publishing | SponsoredHidden on Tesla's filing: A $12 billion "super startup"Tesla's most recent SEC filing contains a single line showing $12 billion in revenue from a new venture Elon M...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Illumina, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Illumina With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
